首页> 美国卫生研究院文献>BMJ Case Reports >Severe urticarial rash as the initial symptom of COVID-19 infection
【2h】

Severe urticarial rash as the initial symptom of COVID-19 infection

机译:严重的荨麻疹作为Covid-19感染的初始症状

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 54-year-old woman presented with pruritic rash and hives of 3 days’ duration followed by shortness of breath for 1 day. SARS-CoV-2 PCR test for COVID-19 was positive. Cutaneous manifestations of COVID-19 include acral lesions, urticarial rash, erythematous maculopapular rash, vascular rashes and vesicular rash. The cutaneous manifestations are mostly described as self-limiting. Urticarial rashes are not reported as the initial presentation symptom of COVID-19 infection but mostly noted to occur at the same time or after the onset of non-cutaneous symptoms. Management of cutaneous manifestations of COVID-19 affecting quality of life has not been well studied. Antihistamine therapy is the primary recommended therapy. Role of antiviral therapy for severe cases of rash needs to be further assessed.
机译:一个54岁的女子患有瘙痒性皮疹和荨麻疹,持续时间为3天,然后呼吸短促1天。 Covid-19的SARS-COV-2 PCR试验是阳性的。 Covid-19的皮肤表现包括急性病变,荨麻疹,红斑狼疮性皮疹,血管皮疹和囊泡皮疹。皮肤表现主要被描述为自我限制。荨麻疹皮疹未被报告为Covid-19感染的初始呈现症状,但大多数人指出,同时发生或在非皮肤症状发作后发生。对影响生活质量的Covid-19无皮肤表现的管理并未得到很好的研究。抗组胺药疗法是主要推荐治疗。抗病毒治疗对皮疹严重病例的作用需要进一步评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号